P408. Differences in biologic efficacy and dose-escalation among anti-TNF agents in Crohn's disease and ulcerative colitis

1. Ana Echarri Piudo
2. Lopez Casado
3. Rebeca Fraga Iriso
4. Virginia Ollero Pena
5. L. García Dieguez

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo lock_openFull text externo

DOI: 10.1093/ECCO-JCC/JJU027.527 GOOGLE SCHOLAR lock_openOpen access editor

More publications in: Journal of Crohn's and Colitis

Sustainable development goals

•